![schermata-2016-10-14-alle-09-13-17](http://www.farmaindustriaticino.ch/files/2016/10/Schermata-2016-10-14-alle-09.13.17-300x37.png)
COPENHAGEN, Denmark, DESSAU, Germany and LUGANO, Switzerland, October 12, 2016
CMC Biologics A/S, a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika GmbH, a privately-held life-science company with a 95 year history of expertise in research, development and manufacture of biologics for human and animal health, announced the addition of Cerbios-Pharma SA (“Cerbios”) and Oncotec Pharma Produktion GmbH (“Oncotec“) to PROVEO, their strategic collaboration for providing a complete and efficient solution to the market for the process development and manufacture of antibody drug conjugates (ADCs).
Linkedin